Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma

被引:0
|
作者
Makler, PT
机构
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:1173 / 1173
页数:1
相关论文
共 50 条
  • [1] Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma
    Gambhir, SS
    Hoh, CK
    Phelps, ME
    Madar, I
    Maddahi, J
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (09) : 1428 - 1436
  • [2] Decision-tree sensitivity analysis for cost-effectiveness of FDG-PET in patients with non-small-cell lung carcinoma
    Kosuda, S
    Ichihara, K
    Watanabe, M
    Kobayashi, H
    Kusano, S
    [J]. POSITRON EMISSION TOMOGRAPHY IN THE MILLENNIUM, 2000, 1197 : 187 - 190
  • [3] Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: A decision analysis
    Scott, WJ
    Shepherd, J
    Gambhir, SS
    [J]. ANNALS OF THORACIC SURGERY, 1998, 66 (06): : 1876 - 1883
  • [4] Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: A decision analysis - Discussion
    Rice, TW
    Naunheim, KS
    Scott
    [J]. ANNALS OF THORACIC SURGERY, 1998, 66 (06): : 1883 - 1884
  • [5] Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small-cell lung carcinoma in Japan
    Kosuda, S
    Ichihara, K
    Watanabe, M
    Kobayashi, H
    Kusano, S
    [J]. ANNALS OF NUCLEAR MEDICINE, 2002, 16 (04) : 263 - 271
  • [6] Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small-cell lung carcinoma in Japan
    Shigeru Kosuda
    Kiyoshi Ichihara
    Masazumi Watanabe
    Hideo Kobayashi
    Shoichi Kusano
    [J]. Annals of Nuclear Medicine, 2002, 16 : 263 - 271
  • [7] Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: A decision analysis - Invited commentary
    Silvestri, GA
    [J]. ANNALS OF THORACIC SURGERY, 1998, 66 (06): : 1884 - 1885
  • [8] Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study
    Paul Verboom
    Harm van Tinteren
    Otto S. Hoekstra
    Egbert F. Smit
    Jan H. A. M. van den Bergh
    Ad J. M. Schreurs
    Roland A. L. M. Stallaert
    Piet C. M. van Velthoven
    Emile F. I. Comans
    Fred W. Diepenhorst
    Johan C. van Mourik
    Pieter E. Postmus
    Maarten Boers
    Els W. M. Grijseels
    Gerrit J. J. Teule
    Carin A. Uyl-de Groot
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 1444 - 1449
  • [9] Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study
    Verboom, P
    van Tinteren, H
    Hoekstra, OS
    Smit, EF
    van den Bergh, JHAM
    Schreurs, AJM
    Stallaert, RALM
    van Velthoven, PCM
    Comans, EFI
    Diepenhorst, FW
    van Mourik, JC
    Postmus, PE
    Boers, M
    Grijseels, EWM
    Teule, GJJ
    Uyl-de Groot, CA
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (11) : 1444 - 1449
  • [10] Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG-pet in patients with a pulmonary nodule non-small cell lung carcinoma in Japan.
    Kosuda, S
    Ichihara, K
    Watanabe, M
    Kobayashi, H
    Kusano, S
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 295P - 295P